INO SCHEDULE 13G/A: SEC filing

Highbridge Capital Management

Filed with the SEC on · accession 0000919574-26-007926

INO filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -2.1% by the first close after the filing.

Summary of the filing

Highbridge Capital Management filed an amended Schedule 13G reporting beneficial ownership of 25,288,217 shares of Inovio Pharmaceuticals common stock issuable upon exercise of warrants, subject to a 9.99% blocker, representing 9.9% of outstanding shares.

Key details

Shares of Common Stock issuable upon exercise of Reported Warrants (beneficial ownership before 9.99% blocker)$25.3M
Aggregate shares of Common Stock outstanding as of August 10, 2026$103.4M
Reporting person / investment adviser to highbridge fundsHighbridge Capital Management, LLC
IssuerInovio Pharmaceuticals, Inc.
Highbridge fund with right to receive dividends/proceeds of more than 5% of outstanding common stockHighbridge Tactical Credit Master Fund, L.P.
Executive directorKirk Rule

How INO stock reacted

Close before

$1.43

Nov 13, 2026

First close after

-2.10%

$1.40

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for INO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for INO?

Click here

Frequently asked questions

What did INO file with the SEC on Nov 16, 2026?

INO filed a SCHEDULE 13G/A (SEC filing). Highbridge Capital Management filed an amended Schedule 13G reporting beneficial ownership of 25,288,217 shares of Inovio Pharmaceuticals common stock issuable upon exercise of warrants, subject to a 9.99% blocker, representing 9.9% of outstanding shares.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did INO stock react to this filing?

INO closed at $1.43 before the filing and $1.40 on Nov 16, 2026 (-2.10%).

Other INO SEC filings

Get alerts when INO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days